{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:37:02Z","timestamp":1774881422683,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijtb.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T01:49:36Z","timestamp":1579052976000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u2018Have we missed reporting adverse drug reactions under Revised National TB Control Programme?\u2019 - A mixed method study in Bengaluru, India"],"prefix":"10.1016","volume":"67","author":[{"given":"Lalitha","family":"Krishnappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Gadicherla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshini","family":"Chidambaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.V.","family":"Anuradha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaraj Nallur","family":"Somanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam Ramesh","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arundhati","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somashekar","family":"Narasimhaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharath Burugina","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2020.01.003_bib1","series-title":"Global Tuberculosis Report 2018 [Internet]","author":"World Health Organization","year":"2018"},{"issue":"5","key":"10.1016\/j.ijtb.2020.01.003_bib2","first-page":"7","article-title":"Adverse drug reactions associated with first line anti tubercular drugs in a tertiary care hospital of Central India\u202f: a study of clinical presentations , causality , and severity","volume":"7","author":"Verma","year":"2014","journal-title":"Asian J Pharmaceut Clin Res [Internet]"},{"issue":"6","key":"10.1016\/j.ijtb.2020.01.003_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4103\/0253-7613.194855","article-title":"Pharmacovigilance Programme of India: recent developments and future perspectives","volume":"48","author":"Kalaiselvan","year":"2016","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ijtb.2020.01.003_bib4","series-title":"A Practical Handbook on the Pharmacovigilance of Medicines Used in the Treatment of Tuberculosis - Enhancing the Safety of the TB Patient [Internet]","author":"World Health Organization","year":"2012"},{"issue":"12","key":"10.1016\/j.ijtb.2020.01.003_bib5","first-page":"165","article-title":"Adverse drug reactions monitoring among TB patients on anti-tubercular drugs under RNTCP in Pondicherry . Aims & Objectives\u202f: methodology\u202f: method of analysis and Statistical tests\u202f: Results","volume":"2","author":"Anusha","year":"2014","journal-title":"Int J Adv Res [Internet]"},{"issue":"1","key":"10.1016\/j.ijtb.2020.01.003_bib6","first-page":"29","article-title":"Side effects of antitubercular drugs on directly observed treatment strategy under revised national tuberculosis control programme in a teaching hospital","volume":"6","author":"Rajanandh","year":"2012","journal-title":"Glob J Pharmacol [Internet]"},{"issue":"2","key":"10.1016\/j.ijtb.2020.01.003_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2320-8775.123213","article-title":"Adverse drug reactions in tuberculosis patients due to directly observed treatment strategy therapy: experience at an outpatient clinic of a teaching hospital in the city of Imphal, Manipur, India","volume":"1","author":"Sinha","year":"2013","journal-title":"J Assoc Chest Physicians [Internet]"},{"issue":"2","key":"10.1016\/j.ijtb.2020.01.003_bib8","first-page":"1395","article-title":"Safety evaluation of antitubercular therapy under Revised National Tuberculosis Control Programme in India","volume":"3","author":"Tak","year":"2009","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ijtb.2020.01.003_bib9","first-page":"27","article-title":"Central TB division; prevention & management of adverse reactions associated with antitubercular drugs","author":"Indian Council of Medical Research","year":"2016","journal-title":"Directorate General of Health Services, Government of India"},{"key":"10.1016\/j.ijtb.2020.01.003_bib10","author":"The Uppsala Monitoring Centre"},{"issue":"6","key":"10.1016\/j.ijtb.2020.01.003_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research: a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care [Internet]"},{"issue":"3","key":"10.1016\/j.ijtb.2020.01.003_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.18203\/2349-3933.ijam20171512","article-title":"Impact of adverse drug reaction of first line anti - tuberculous drugs on treatment outcome of tuberculosis under revised national tuberculosis control programme","volume":"4","author":"Dedun","year":"2017","journal-title":"Int J Adv Med"},{"issue":"8","key":"10.1016\/j.ijtb.2020.01.003_bib13","first-page":"2279","article-title":"A pharmacovigilance study on antitubercular therapy in the department of pulmonary medicine at a tertiary care hospital","volume":"14","author":"Sreekanth","year":"2015","journal-title":"IOSR J Dent Med Sci [Internet]"},{"issue":"1","key":"10.1016\/j.ijtb.2020.01.003_bib14","first-page":"6","article-title":"Adverse reactions due to directly observed treatment short course Therapy\u202f: an Indian prospective study","volume":"3","author":"Nanda","year":"2016","journal-title":"IAIM [Internet]"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570720300032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570720300032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:24:32Z","timestamp":1762176272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570720300032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0019570720300032"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2020.01.003","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u2018Have we missed reporting adverse drug reactions under Revised National TB Control Programme?\u2019 - A mixed method study in Bengaluru, India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}